New hybrid analogs were evaluated against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) in order to know their potential for the prevention of Alzheimer's disease (AD). The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.